Sex-specific and race/ethnicity-specific disparities in cholangiocarcinoma incidence and prevalence in the USA: An updated analysis of the 2000–2011 Surveillance, Epidemiology and End Results registry

Hepatology Research

Volumn 46, Issue 7, 2016, Pages 669-677

  Mosadeghi, Sasan ^a   Liu, Benny ^a   Bhuket, Taft ^a   Wong, Robert J ^a  

^a HIGHLAND HOSPITAL   (United States)

Author keywords

cholangiocarcinoma; extrahepatic; intrahepatic; race ethnicity; Surveillance, Epidemiology and End Results

Indexed keywords

ADULT; AFRICAN AMERICAN; AGE DISTRIBUTION; AGED; ARTICLE; ASIAN; BILE DUCT CARCINOMA; CANCER INCIDENCE; CANCER REGISTRY; CONTROLLED STUDY; ETHNICITY; EXTRAHEPATIC CHOLANGIOCARCINOMA; FEMALE; HISPANIC; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; RACE; RETROSPECTIVE STUDY; SEX DIFFERENCE; UNITED STATES;

EID: 84975093510     PISSN: 13866346     EISSN: 1872034X     Source Type: Journal    
DOI: 10.1111/hepr.12605     Document Type: Article

References (32)

1. Poultsides GA, Zhu AX, Choti MA et al. Intrahepatic cholangiocarcinoma. Surg Clin North Am 2010; 90: 817–37.
2. Welzel TM, Graubard BI, El-Serag HB et al. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case–control study. Clin Gastroenterol Hepatol 2007; 5: 1221–8.
3. Khan SA, Thomas HC, Davidson BR et al. Cholangiocarcinoma. Lancet 2005; 366: 1303–14.
4. Lazaridis KN, Gores GJ. Cholangiocarcinoma. Gastroenterology 2005; 128: 1655–67.
5. Shaib Y, El-Serag HB. The epidemiology of cholangiocarcinoma. Semin Liver Dis 2004; 24: 115–25.
6. Bergquist A, Glaumann H, Lindberg B et al. Primary sclerosing cholangitis can present with acute liver failure: Report of two cases. J Hepatol 2006; 44: 1005–8.
7. Broome U, Glaumann H, Lindstom E et al. Natural history and outcome in 32 Swedish patients with small duct primary sclerosing cholangitis (PSC). J Hepatol 2002; 36: 586–9.
8. Chalasani N, Baluyut A, Ismail A et al. Cholangiocarcinoma in patients with primary sclerosing cholangitis: a multicenter case–control study. Hepatology 2000; 31: 7–11.
9. Gupta AK, Gupta A, Bhardwaj VK et al. Caroli's disease. Indian J Pediatr 2006; 73: 233–5.
10. Singal AG, Rakoski MO, Salgia R et al. The clinical presentation and prognostic factors for intrahepatic and extrahepatic cholangiocarcinoma in a tertiary care centre. Aliment Pharmacol Ther 2010; 31: 625–33.
11. Patel T. Worldwide trends in mortality from biliary tract malignancies. BMC Cancer 2002; 2: 10.
12. Jemal A, Murray T, Samuels A et al. Cancer statistics, 2003. CA Cancer J Clin 2003; 53: 5–26.
13. Shaib YH, Davila JA, McGlynn K et al. Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase? J Hepatol 2004; 40: 472–7.
14. Carriaga MT, Henson DE. Liver, gallbladder, extrahepatic bile ducts, and pancreas. Cancer 1995; 75: 171–90.
15. Singal A, Welling TH, Marrero JA. Role of liver transplantation in the treatment of cholangiocarcinoma. Expert Rev Anticancer Ther 2009; 9: 491–502.
16. Nguyen GC, Thuluvath PJ. Racial disparity in liver disease: Biological, cultural, or socioeconomic factors. Hepatology 2008; 47: 1058–66.
17. Kneuertz PJ, Kao LS, Ko TC et al. Regional disparities affect treatment and survival of patients with intrahepatic cholangiocarcinoma–a Texas Cancer Registry analysis. J Surg Oncol 2014; 110: 416–21.
18. McLean L, Patel T. Racial and ethnic variations in the epidemiology of intrahepatic cholangiocarcinoma in the United States. Liver Int 2006; 26: 1047–53.
19. Silva I. Cancer Epidemiology: Principles and Methods. Geneva, Switzerland: World Health Organization, 1999.
20. Singal AK, Vauthey JN, Grady JJ et al. Intra-hepatic cholangiocarcinoma–frequency and demographic patterns: thirty-year data from the M.D. Anderson Cancer Center. J Cancer Res Clin Oncol 2011; 137: 1071–8.
21. Khan SA, Toledano MB, Taylor-Robinson SD. Epidemiology, risk factors, and pathogenesis of cholangiocarcinoma. HPB (Oxford) 2008; 10: 77–82.
22. Zhou HB, Hu JY, Hu HP. Hepatitis B virus infection and intrahepatic cholangiocarcinoma. World J Gastroenterol 2014; 20: 5721–9.
23. Li M, Li J, Li P et al. Hepatitis B virus infection increases the risk of cholangiocarcinoma: a meta-analysis and systematic review. J Gastroenterol Hepatol 2012; 27: 1561–8.
24. Palmer WC, Patel T. Are common factors involved in the pathogenesis of primary liver cancers? A meta-analysis of risk factors for intrahepatic cholangiocarcinoma. J Hepatol 2012; 57: 69–76.
25. Zhou Y, Zhao Y, Li B et al. Hepatitis viruses infection and risk of intrahepatic cholangiocarcinoma: evidence from a meta-analysis. BMC Cancer 2012; 12: 289.
26. Fried B, Abruzzi A. Food-borne trematode infections of humans in the United States of America. Parasitol Res 2010; 106: 1263–80.
27. Li H, Hu B, Zhou ZQ et al. Hepatitis C virus infection and the risk of intrahepatic cholangiocarcinoma and extrahepatic cholangiocarcinoma: evidence from a systematic review and meta-analysis of 16 case–control studies. World J Surg Oncol 2015; 13: 161.
28. Welzel TM, McGlynn KA, Hsing AW et al. Impact of classification of hilar cholangiocarcinomas (Klatskin tumors) on the incidence of intra- and extrahepatic cholangiocarcinoma in the United States. J Natl Cancer Inst 2006; 98: 873–5.
29. Khan SA, Emadossadaty S, Ladep NG et al. Rising trends in cholangiocarcinoma: is the ICD classification system misleading us? J Hepatol 2012; 56: 848–54.
30. Tyson GL, Ilyas JA, Duan Z et al. Secular trends in the incidence of cholangiocarcinoma in the USA and the impact of misclassification. Dig Dis Sci 2014; 59: 3103–10.
31. Miyazaki M, Ohtsuka M, Miyakawa S et al. Classification of biliary tract cancers established by the Japanese Society of Hepato-Biliary-Pancreatic Surgery: 3(rd) English edition. J Hepatobiliary Pancreat Sci 2015; 22: 181–96.
32. Ohtsuka M, Miyakawa S, Nagino M et al. Revision concepts and distinctive points of the new Japanese classification for biliary tract cancers in comparison with the 7(th) edition of the Union for International Cancer Control and the American Joint Committee on Cancer staging system. J Hepatobiliary Pancreat Sci 2015; 22: 197–201.